如何选择左心室辅助装置（LVAD）的患者。
How to select a patient for LVAD.
作者信息
Cordero-Cabán Kathia, Ssembajjwe Brian, Patel Jay, Abramov Dmitry
机构信息
Internal Medicine Department, Loma Linda University Medical Center, 11234 Anderson St, Loma Linda, CA 92354 USA.
Division of Cardiology, Loma Linda Veterans Administration Healthcare System, Loma Linda, CA USA.
出版信息
Indian J Thorac Cardiovasc Surg. 2023 Jul;39(Suppl 1):8-17. doi: 10.1007/s12055-022-01428-w. Epub 2022 Dec 15.
Abstract
Left ventricular assist device (LVAD) implantation leads to improvement in symptoms and survival in patients with advanced heart failure. An important factor in improving outcomes post-LVAD implantation is optimal preoperative patient selection and optimization. In this review, we highlight the latest on the evaluation of patients with advanced heart failure for LVAD candidacy, including discussion of patient selection, implantation timing, laboratory and other testing considerations, and the importance of psychosocial evaluation. Such thorough evaluation by multidisciplinary team can serve to improve the outcomes of a complex group of patients with advanced heart failure being evaluated for LVAD.
摘要
植入左心室辅助装置（LVAD）可改善晚期心力衰竭患者的症状并提高其生存率。提高LVAD植入术后疗效的一个重要因素是术前对患者进行最佳选择和优化。在本综述中，我们重点介绍了晚期心力衰竭患者LVAD植入候选评估的最新情况，包括患者选择、植入时机、实验室及其他检查考量，以及社会心理评估的重要性。多学科团队进行的这种全面评估有助于改善一组正在接受LVAD评估的复杂晚期心力衰竭患者的治疗效果。
相似文献
1
How to select a patient for LVAD.如何选择左心室辅助装置（LVAD）的患者。
Indian J Thorac Cardiovasc Surg. 2023 Jul;39(Suppl 1):8-17. doi: 10.1007/s12055-022-01428-w. Epub 2022 Dec 15.
2
Virtual implantation and patient-specific simulation for optimization of outcomes in ventricular assist device recipients.虚拟植入和针对心室辅助装置接受者的个性化模拟以优化治疗效果
Med Hypotheses. 2016 Jun;91:67-72. doi: 10.1016/j.mehy.2016.04.003. Epub 2016 Apr 7.
3
Patient-Reported Health-Related Quality of Life Is a Predictor of Outcomes in Ambulatory Heart Failure Patients Treated With Left Ventricular Assist Device Compared With Medical Management: Results From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management).与药物治疗相比，患者报告的健康相关生活质量是接受左心室辅助装置治疗的门诊心力衰竭患者预后的预测指标：ROADMAP研究（左心室辅助装置与药物治疗的风险评估及比较效果）结果
Circ Heart Fail. 2017 Jun;10(6). doi: 10.1161/CIRCHEARTFAILURE.116.003910.
4
Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients).西雅图心力衰竭模型和HeartMate II风险评分在非依赖血管活性药物的晚期心力衰竭患者中的准确性：ROADMAP研究（门诊心力衰竭患者左心室辅助装置与药物治疗的风险评估及比较效果）的见解
Circ Heart Fail. 2017 May;10(5). doi: 10.1161/CIRCHEARTFAILURE.116.003745.
5
Psychosocial Risk and Its Association With Outcomes in Continuous-Flow Left Ventricular Assist Device Patients.心理社会风险及其与连续血流左心室辅助装置患者结局的关系。
Circ Heart Fail. 2020 Sep;13(9):e006910. doi: 10.1161/CIRCHEARTFAILURE.120.006910. Epub 2020 Sep 8.
6
Preoperative evaluation and perioperative management of right ventricular failure after left ventricular assist device implantation.左心室辅助装置植入术后右心室衰竭的术前评估与围手术期管理
Semin Cardiothorac Vasc Anesth. 2013 Dec;17(4):249-61. doi: 10.1177/1089253213488246. Epub 2013 May 2.
7
Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.左心室辅助装置植入作为终末期治疗在 REMATCH 时代后的结局：对患者选择的启示。
Circulation. 2007 Jul 31;116(5):497-505. doi: 10.1161/CIRCULATIONAHA.107.691972. Epub 2007 Jul 16.
8
MitraClip procedure prior to left ventricular assist device implantation.在植入左心室辅助装置之前进行二尖瓣夹合术。
J Thorac Dis. 2018 Jun;10(Suppl 15):S1763-S1768. doi: 10.21037/jtd.2018.05.36.
9
Prognostic Value of Natriuretic Peptides for All-Cause Mortality, Right Ventricular Failure, Major Adverse Events, and Myocardial Recovery in Advanced Heart Failure Patients Receiving a Left Ventricular Assist Device: A Systematic Review.利钠肽对接受左心室辅助装置的晚期心力衰竭患者全因死亡率、右心室衰竭、主要不良事件及心肌恢复的预后价值：一项系统评价
Front Cardiovasc Med. 2021 Jul 7;8:699492. doi: 10.3389/fcvm.2021.699492. eCollection 2021.
10
Spleen size improvement in advanced heart failure patients using a left ventricular assist device.使用左心室辅助装置改善晚期心力衰竭患者的脾脏大小。
Artif Organs. 2020 Jul;44(7):700-708. doi: 10.1111/aor.13658. Epub 2020 Feb 24.
本文引用的文献
1
The effect of recipient BMI on waitlist and post-transplant outcomes after the 2018 heart transplant allocation policy change.2018 年心脏移植分配政策改变后，受者 BMI 对等待名单和移植后结果的影响。
J Card Surg. 2022 Jul;37(7):1896-1904. doi: 10.1111/jocs.16432. Epub 2022 Apr 5.
2
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
J Am Coll Cardiol. 2022 May 3;79(17):e263-e421. doi: 10.1016/j.jacc.2021.12.012. Epub 2022 Apr 1.
3
Comparison of feasibility and results of frailty assessment methods prior to left ventricular assist device implantation.比较左心室辅助装置植入术前评估虚弱方法的可行性和结果。
ESC Heart Fail. 2022 Apr;9(2):1038-1049. doi: 10.1002/ehf2.13764. Epub 2022 Jan 6.
4
Strategies for Mechanical Right Ventricular Support During Left Ventricular Assist Device Implant.左心室辅助装置植入期间机械右心室支持的策略。
Ann Thorac Surg. 2022 Aug;114(2):484-491. doi: 10.1016/j.athoracsur.2021.10.032. Epub 2021 Nov 26.
5
Natural History and Prognosis of Patients with Unrepaired Tricuspid Regurgitation Undergoing Implantation of Left Ventricular Assist Device.未修复三尖瓣反流患者植入左心室辅助装置的自然史和预后。
ASAIO J. 2022 Apr 1;68(4):508-515. doi: 10.1097/MAT.0000000000001521.
6
Impact of heart transplant allocation change on competing waitlist outcomes among listing strategies.心脏移植分配变更对不同列入名单策略的候补名单竞争结局的影响。
Clin Transplant. 2021 Jul;35(7):e14345. doi: 10.1111/ctr.14345. Epub 2021 Jun 6.
7
Left Ventricular End-Diastolic Dimension and Clinical Outcomes After Centrifugal Flow Left Ventricular Assist Device Implantation.左心室舒张末期内径与离心流左心室辅助装置植入后的临床结局。
ASAIO J. 2022 Feb 1;68(2):220-225. doi: 10.1097/MAT.0000000000001449.
8
Assessing in-hospital cardiovascular, thrombotic and bleeding outcomes in patients with chronic liver disease undergoing left ventricular assist device implantation.评估慢性肝病患者行左心室辅助装置植入术后的院内心血管、血栓和出血结局。
Thromb Res. 2021 Jun;202:184-190. doi: 10.1016/j.thromres.2021.04.010. Epub 2021 Apr 19.
9
Mitral and aortic valve surgery during left ventricular assist device implantation.左心室辅助装置植入期间的二尖瓣和主动脉瓣手术。
J Thorac Cardiovasc Surg. 2022 Sep;164(3):970-977. doi: 10.1016/j.jtcvs.2021.01.144. Epub 2021 Mar 18.
10
Creation and Validation of a Novel Sex-Specific Mortality Risk Score in LVAD Recipients.创建并验证了一个适用于 LVAD 受者的新型性别特异性死亡率风险评分。
J Am Heart Assoc. 2021 Apr 6;10(7):e020019. doi: 10.1161/JAHA.120.020019. Epub 2021 Mar 25.
Zotero 插件